TETRAPHASE PHARMACEUTICALS INC Long-Term Debt, Maturity, Year Three
TETRAPHASE PHARMACEUTICALS INC had Long-Term Debt, Maturity, Year Three of $9.23 million as of 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree · last filed 2019-08-08
- 2019-06-30: Long-Term Debt, Maturity, Year Three $9.23M.
- 2019-03-31: Long-Term Debt, Maturity, Year Three $9.23M.
- 2018-12-31: Long-Term Debt, Maturity, Year Three $9.23M.
- 2014-09-30: Long-Term Debt, Maturity, Year Three $1.13M.
| Period end | Long-Term Debt, Maturity, Year Three |
|---|---|
| 2019-06-30 | $9.23M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $9.23M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $9.23M 10-K · filed 2019-03-15 |
| 2014-09-30 | $1.13M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $1.13M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $1.13M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $1.13M 10-K · filed 2014-03-06 |
| 2013-09-30 | $3.51M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $1.13M 10-Q · filed 2013-08-12 |
| 2013-03-31 | $1.13M 10-Q · filed 2013-05-13 |